BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 30729512)

  • 21. Autologous stem cell transplantation in the treatment of multiple myeloma with 17p deletion.
    Czyż J; Jurczyszyn A; Szudy-Szczyrek A; Koclęga A; Jachalska A; Dzierżak-Mietła M; Puła B; Jamroziak K; Usnarska-Zubkiewicz L; Gil L; Romejko-Jarosińska J; Waszczuk-Gajda A
    Pol Arch Intern Med; 2020 Feb; 130(2):106-111. PubMed ID: 31933484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adults.
    Schaaf M; Reiser M; Borchmann P; Engert A; Skoetz N
    Cochrane Database Syst Rev; 2012 Jan; 1():CD007678. PubMed ID: 22258971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcome of a Salvage Third Autologous Stem Cell Transplantation in Multiple Myeloma.
    Garderet L; Iacobelli S; Koster L; Goldschmidt H; Johansson JE; Bourhis JH; Krejci M; Leleu X; Potter M; Blaise D; Koenecke C; Peschel C; Radocha J; Metzner B; Lenain P; Schäfer-Eckart K; Pohlreich D; Grasso M; Caillot D; Einsele H; Ladetto M; Schönland S; Kröger N
    Biol Blood Marrow Transplant; 2018 Jul; 24(7):1372-1378. PubMed ID: 29408334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autologous stem cell transplantation for elderly patients with newly diagnosed multiple myeloma in the era of novel agents.
    Merz M; Neben K; Raab MS; Sauer S; Egerer G; Hundemer M; Hose D; Kunz C; Heiß C; Ho AD; Goldschmidt H; Hillengass J
    Ann Oncol; 2014 Jan; 25(1):189-95. PubMed ID: 24356629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk and response adapted therapy following autologous stem cell transplant in patients with newly diagnosed multiple myeloma (RADAR (UK-MRA Myeloma XV Trial): study protocol for a phase II/III randomised controlled trial.
    Royle KL; Coulson AB; Ramasamy K; Cairns DA; Hockaday A; Quezada S; Drayson M; Kaiser M; Owen R; Auner HW; Cook G; Meads D; Olivier C; Barnard L; Lambkin R; Paterson A; Dawkins B; Chapman M; Pratt G; Popat R; Jackson G; Bygrave C; Sive J; de Tute R; Chantry A; Parrish C; Cook M; Asher S; Yong K
    BMJ Open; 2022 Nov; 12(11):e063037. PubMed ID: 36396306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple Myeloma-Effect of Induction Therapy on Transplant Outcomes.
    Kumar L; Gundu N; Kancharia H; Sahoo RK; Malik PS; Sharma A; Gupta R; Sharma O; Biswas A; Kumar R; Thulkar S; Mallick S;
    Clin Lymphoma Myeloma Leuk; 2021 Feb; 21(2):80-90.e5. PubMed ID: 33129746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of chromosome 13 deletion and plasma cell load on long-term survival of patients with multiple myeloma undergoing autologous transplantation.
    Paul E; Sutlu T; Deneberg S; Alici E; Björkstrand B; Jansson M; Lerner R; Wallblom A; Gahrton G; Nahi H
    Oncol Rep; 2009 Jul; 22(1):137-42. PubMed ID: 19513515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complex karyotype and translocation t(4;14) define patients with high-risk newly diagnosed multiple myeloma: results of CMG2002 trial.
    Nemec P; Zemanova Z; Kuglik P; Michalova K; Tajtlova J; Kaisarova P; Oltova A; Filkova H; Holzerova M; Balcarkova J; Jarosova M; Rabasova J; Hruba M; Spicka I; Gregora E; Adam Z; Scudla V; Maisnar V; Schutzova M; Hajek R;
    Leuk Lymphoma; 2012 May; 53(5):920-7. PubMed ID: 22023516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination of international scoring system 3, high lactate dehydrogenase, and t(4;14) and/or del(17p) identifies patients with multiple myeloma (MM) treated with front-line autologous stem-cell transplantation at high risk of early MM progression-related death.
    Moreau P; Cavo M; Sonneveld P; Rosinol L; Attal M; Pezzi A; Goldschmidt H; Lahuerta JJ; Marit G; Palumbo A; van der Holt B; Bladé J; Petrucci MT; Neben K; san Miguel J; Patriarca F; Lokhorst H; Zamagni E; Hulin C; Gutierrez N; Facon T; Caillot D; Benboubker L; Harousseau JL; Leleu X; Avet-Loiseau H; Mary JY
    J Clin Oncol; 2014 Jul; 32(20):2173-80. PubMed ID: 24888806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive value of post-transplant bone marrow plasma cell percent in multiple myeloma patients undergone autologous transplantation.
    Hwang IH; Chung JS; Shin HJ; Choi YJ; Song MK; Seol YM; Cho GJ; Choi BG; Choi MK; Choi BK; Ahn KH; Shin KH; Lee HS; Nam HS; Hwang JM
    Korean J Intern Med; 2011 Mar; 26(1):76-81. PubMed ID: 21437166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autologous transplant vs oral chemotherapy and lenalidomide in newly diagnosed young myeloma patients: a pooled analysis.
    Gay F; Oliva S; Petrucci MT; Montefusco V; Conticello C; Musto P; Catalano L; Evangelista A; Spada S; Campbell P; Ria R; Salvini M; Offidani M; Carella AM; Omedé P; Liberati AM; Troia R; Cafro AM; Malfitano A; Falcone AP; Caravita T; Patriarca F; Nagler A; Spencer A; Hajek R; Palumbo A; Boccadoro M
    Leukemia; 2017 Aug; 31(8):1727-1734. PubMed ID: 28008174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase II study of bortezomib, cyclophosphamide and dexamethasone as induction therapy in multiple myeloma: DSMM XI trial.
    Einsele H; Engelhardt M; Tapprich C; Müller J; Liebisch P; Langer C; Kropff M; Mügge LO; Jung W; Wolf HH; Metzner B; Hart C; Gramatzki M; Hertenstein B; Pfreundschuh M; Rösler W; Fischer T; Maschmeyer G; Kanz L; Hess G; Jäger E; Bentz M; Dürk HA; Salwender H; Hebart H; Straka C; Knop S
    Br J Haematol; 2017 Nov; 179(4):586-597. PubMed ID: 28961309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Second autologous transplant as salvage therapy in multiple myeloma.
    Atanackovic D; Schilling G
    Br J Haematol; 2013 Dec; 163(5):565-72. PubMed ID: 24111632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autologous retransplantation for patients with recurrent multiple myeloma: a single-center experience with 200 patients.
    Sellner L; Heiss C; Benner A; Raab MS; Hillengass J; Hose D; Lehners N; Egerer G; Ho AD; Goldschmidt H; Neben K
    Cancer; 2013 Jul; 119(13):2438-46. PubMed ID: 23576287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Real-world advantage and challenge of post-autologous stem cell transplantation MRD negativity in high-risk patients with double-hit multiple myeloma.
    Tao Y; Jin S; Yang D; Pan M; Ouyang W; Liu Y; Wang Y; Zhang W; Mi J
    BMC Cancer; 2024 Apr; 24(1):406. PubMed ID: 38565996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of Autologous Transplantation in Patients with Multiple Myeloma with t(11;14): A Propensity-Score Matched Analysis.
    Saini N; Ma J; Milton DR; Patel R; Varma A; Bashir Q; Delgado R; Mukherjee A; Rondon G; Popat UR; Hosing CM; Nieto Y; Kebriaei P; Alousi AM; Ahmed S; Tang G; Mehta R; Srour S; Khouri IF; Iyer S; Weber DM; Thomas SK; Lee HC; Manasanch EE; Patel KK; Orlowski RZ; Champlin RE; Qazilbash MH
    Clin Cancer Res; 2019 Nov; 25(22):6781-6787. PubMed ID: 31481508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating Plasma Cells at the Time of Collection of Autologous PBSC for Transplant in Multiple Myeloma Patients is a Negative Prognostic Factor Even in the Age of Post-Transplant Maintenance Therapy.
    Cowan AJ; Stevenson PA; Libby EN; Becker PS; Coffey DG; Green DJ; Hyun TS; Fromm JR; Gopal AK; Holmberg LA
    Biol Blood Marrow Transplant; 2018 Jul; 24(7):1386-1391. PubMed ID: 29481870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Importance of achieving stringent complete response after autologous stem-cell transplantation in multiple myeloma.
    Kapoor P; Kumar SK; Dispenzieri A; Lacy MQ; Buadi F; Dingli D; Russell SJ; Hayman SR; Witzig TE; Lust JA; Leung N; Lin Y; Zeldenrust SR; McCurdy A; Greipp PR; Kyle RA; Rajkumar SV; Gertz MA
    J Clin Oncol; 2013 Dec; 31(36):4529-35. PubMed ID: 24248686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and prognostic significance of t(4;14) translocation in multiple myeloma in the era of novel agents.
    Sato S; Kamata W; Okada S; Tamai Y
    Int J Hematol; 2021 Feb; 113(2):207-213. PubMed ID: 32949373
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical Implications of t(11;14) in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation.
    Takamatsu H; Yamashita T; Kurahashi S; Saitoh T; Kondo T; Maeda T; Nakazawa H; Murata M; Narita T; Kuroda J; Hashimoto H; Kawamura K; Miyamoto T; Honda S; Ichinohe T; Atsuta Y; Sunami K
    Biol Blood Marrow Transplant; 2019 Mar; 25(3):474-479. PubMed ID: 30423479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.